Home/Filings/4/0001209191-22-043766
4//SEC Filing

Sank Leonard 4

Accession 0001209191-22-043766

CIK 0001176309other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 8:00 PM ET

Size

5.3 KB

Accession

0001209191-22-043766

Insider Transaction Report

Form 4
Period: 2022-07-28
Sank Leonard
Director
Transactions
  • Award

    Common Stock

    2022-07-28+12,00018,000 total
Footnotes (2)
  • [F1]Represents Restricted Stock Units ("RSUs") that will vest in 3 installments as follows: 4,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
  • [F2]The reporting person previously reported and disclaimed beneficial ownership over 138,889 shares of common stock owned by a company wholly owned by a trust of which the reporting person was previously a trustee. The reporting person resigned as a trustee of such trust, effective February 3, 2022.

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1
  • filerCIK 0001416089

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 8:00 PM ET
Size
5.3 KB